Kiniksa Pharmaceuticals to Present at 43rd Annual J.P. Morgan Healthcare Conference
Kiniksa Pharmaceuticals to Present at 43rd Annual J.P. Morgan Healthcare Conference
LONDON, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that it will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025 at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time).
倫敦，2025年1月6日（全球新聞通訊）-- Kiniksa Pharmaceuticals International, plc（納斯達克：KNSA）今天宣佈，它將在2025年1月13日（星期一）太平洋時間下午1:30（東部時間下午4:30）參加第43屆年度J.P.摩根醫療會議。
A live webcast of Kiniksa's presentation will be accessible through the Investors section of the company's website at . A replay of the event will also be available on Kiniksa's website within approximately 48 hours after the event.
Kiniksa的演講將通過公司網站的投資者板塊進行現場直播。活動的重播將在活動結束後大約48小時內在Kiniksa的網站上提供。
About Kiniksa
Kiniksa is a commercial-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Kiniksa's immune-modulating assets are based on strong biologic rationale or validated mechanisms, target a spectrum of underserved cardiovascular and autoimmune conditions, and offer the potential for differentiation. For more information, please visit .
關於Kiniksa
Kiniksa是一家處於商業階段的生物製藥公司，專注於發現、收購、開發和商業化治療藥物，以幫助那些面臨重大醫療需求的疾病患者。Kiniksa的免疫調節資產基於強有力的生物學理論或經過驗證的機制，針對一系列被忽視的心血管和自身免疫疾病，並提供差異化的潛力。欲了解更多信息，請訪問。
Every Second Counts!
每一秒都很重要！
Kiniksa Investor Contact
Jonathan Kirshenbaum
(781) 829-3949
jkirshenbaum@kiniksa.com
Kiniksa投資者聯繫
喬納森·基爾申鮑姆
(781) 829-3949
jkirshenbaum@kiniksa.com
Kiniksa Media Contact
Tyler Gagnon
(781) 431-9100
tgagnon@kiniksa.com
Kiniksa媒體聯繫
泰勒·加農
(781) 431-9100
tgagnon@kiniksa.com
譯文內容由第三人軟體翻譯。